Zelos Therapeutics is an emerging private biopharmaceutical development company that is commercializing breakthrough discoveries in parathyroid hormone (PTH) research. The company is developing medications for the treatment of osteoporosis, psoriasis and for enhancing engraftment following stem cell transplantation.During 2005, Zelos Therapeutics experienced a number of significant milestones. Key programs at Zelos moved quickly ahead to their next developmental stage during the year. The lead program, injectable Ostabolin-C™ for the treatment of osteoporosis, completed a series of three Phase I trials in Canada in 2004-05 and began Phase II testing at hospital and clinic sites in Canada and the USA. The second program, Ostabolin-C™ gel for topical treatment of psoriasis, began Phase I safety testing in humans this year at sites in the USA. In addition, an inhalation powder version of Ostabolin-C™ for osteoporosis is being tested in animals, in preparation for human safety testing next year. Scientific efforts in a fourth program have recently yielded exciting results in an animal cancer model, and this fourth program will also move into the clinic for human testing next year.The four Zelos programs are currently being advanced by a staff of 12 employees, of whom 10 are based in Ottawa, with the company’s CEO, Dr. Brian MacDonald, based in Philadelphia. Dr. Paul Morley and Mr. Godfrey Marchand, the founders of the company, have demonstrated exceptional entrepreneurial and leadership skills in bringing the company to a mature state over the five years since the company, formerly known as ParaTecH, was founded in 2000. Their partnership represents a perfect balance between science and business: Dr. Morley’s scientific expertise enabled him to recognize an excellent candidate molecule for the treatment of osteoporosis, and Mr. Marchand’s honed business acumen translated the idea into a full-blown biotechnology platform. Through their efforts, the company has created highly skilled full-time drug development jobs, and a working environment where they motivate and mentor their staff.
Zelos Therapeutics Inc is Ottawa-based company (Ontario, Canada) with a phone number 6137470616. Our data show that the company is located at the address: 1730 Street Laurent Boulevard Suite 400. The company has a web site: www.zelostherapeutics.com.
Unfortunately сompany staff has not yet provided of company's activities, mission and detailed description.